Evidence
Crit Rev Oncol Hematol. 2024 May 28:104401. doi: 10.1016/j.critrevonc.2024.104401. Online ahead of print.
ABSTRACT
Several observations indicate that protein expression analysis by immunohistochemistry (IHC) remains relevant in individuals with non-small-cell lung cancer (NSCLC) when considering targeted therapy, as an early step in diagnosis and for therapy selection. Since the advent of next-generation sequencing (NGS), the role of IHC in testing for NSCLC biomarkers has been forgotten or ignored. We discuss how protein-level investigations maintain a critical role in defining sensitivity to lung cancer therapies in oncogene- and non-oncogene-addicted cases and in patients eligible for immunotherapy, suggesting that IHC testing should be reconsidered in clinical practice. We also argue how a panel of IHC tests should be considered complementary to NGS and other genomic assays. This is relevant to current clinical diagnostic practice but with potential future roles to optimize the selection of patients for innovative therapies. At the same time, strict validation of antibodies, assays, scoring systems, and intra- and interobserver reproducibility is needed.
PMID:38815876 | DOI:10.1016/j.critrevonc.2024.104401
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Rediscovering immunohistochemistry in lung cancer
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience
- Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
- Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- Unravelling the diagnostic pathology and molecular biomarkers in lung cancer
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1
- Disulfiram/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis
- Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk
- Phase II study of brigatinib in patients with ROS1 fusion-positive non-small-cell lung cancer: the Barossa study
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- PathoDuet: Foundation models for pathological slide analysis of H&E and IHC stains
- Radiotherapy protocol compliance in routine clinical practice for patients with stages I-III non-small-cell lung cancer
- Radiotherapy protocol compliance in routine clinical practice for patients with stages I-III non-small-cell lung cancer
- Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
- Prediction of dose distributions for non-small cell lung cancer patients using MHA-ResUNet
- Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer
- Clinical-Grade Validation of an Autofluorescence Virtual Staining System with Human Experts and a Deep Learning System for Prostate Cancer
- CUNet3+: A Multi-scale Connected UNet for the Segmentation of Lung Cancer Cells in Pathology Sections Stained using Rapid On-Site Cytopathological Evaluation
- Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases
- p27 specifically decreases in squamous carcinoma, and mediates NNK-induced transformation of human bronchial epithelial cells
- The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort
- Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry
- Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry
- Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports
- Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report
- Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer
- Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature
- Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature
- Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
- Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?
- Patterns of brain metastases response to immunotherapy with pembrolizumab
- Cutaneous Oncology: Strategies for Melanoma Prevention, Diagnosis, and Therapy
- Immune cell infiltration and inflammatory landscape in primary brain tumours
- Exomic and epigenomic analysis of pulmonary blastoma
- Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2
- Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)
- Relationships among self-disclosure, social support and psychological distress in caregivers of patients with advanced lung cancer: A mediating model
- Relationships among self-disclosure, social support and psychological distress in caregivers of patients with advanced lung cancer: A mediating model
- Systematic review and meta-analysis of deep learning applications in computed tomography lung cancer segmentation
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- Association between exposure to organophosphate flame retardants and epidermal growth factor receptor expression in lung cancer patients
- Increased opioid consumption in neoadjuvant immunotherapy plus chemotherapy for patients with non-small-cell lung cancer: A multicenter, prospective cohort study
- Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma
- Artificial Intelligence: Can It Save Lives, Hospitals and Lung Screening?
- Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib
- Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy
- Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
- Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
- Perioperative imaging predictors of tumor progression and pseudoprogression: a systematic review
- Associations Among Changes in Meridian Energy, Quality of Life During Surgery, and Prognoses in Newly Diagnosed Lung Cancer Patients: A Longitudinal Study
- The HUNT lung-SNP model: genetic variants plus clinical variables improve lung cancer risk assessment over clinical models
- Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK
- Comparison of lung ultrasound assisted by artificial intelligence to radiology examination in pneumothorax
- Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours
- Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours
- Applications of Nanopore sequencing in precision cancer medicine
- Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening
- Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening
- Genome-wide association study indicates novel associations of annexin A13 to secretory and GAS2L2 with mucous otitis media
Evidence Blueprint
Rediscovering immunohistochemistry in lung cancer
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Rediscovering immunohistochemistry in lung cancer
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- New options and open issues in the management of unresectable stage III and in early-stage NSCLC: a report from an expert panel of Italian medical and radiation oncologists - INTERACTION GROUP
- Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience
- Lung cancer oncogene-directed therapy, fertility and pregnancy
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy
- Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
- Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- Unravelling the diagnostic pathology and molecular biomarkers in lung cancer
- The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings
- Recent advances in lung cancer research: unravelling the future of treatment
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Critical role of the gut microbiota in immune responses and cancer immunotherapy
- Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape
- New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors
- Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC
- Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report
- Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?
- Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1
- Disulfiram/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis
- Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk
- Phase II study of brigatinib in patients with ROS1 fusion-positive non-small-cell lung cancer: the Barossa study
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- New funding for development of world's first lung cancer vaccine
- HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
- Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p
- PathoDuet: Foundation models for pathological slide analysis of H&E and IHC stains
- Racial/Ethnic disparities in exposure to neighborhood violence and lung cancer risk in Chicago
- Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition
- Radiotherapy protocol compliance in routine clinical practice for patients with stages I-III non-small-cell lung cancer
- Radiotherapy protocol compliance in routine clinical practice for patients with stages I-III non-small-cell lung cancer
- Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
- Prediction of dose distributions for non-small cell lung cancer patients using MHA-ResUNet
- Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT
- Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer
- Clinical-Grade Validation of an Autofluorescence Virtual Staining System with Human Experts and a Deep Learning System for Prostate Cancer
- CUNet3+: A Multi-scale Connected UNet for the Segmentation of Lung Cancer Cells in Pathology Sections Stained using Rapid On-Site Cytopathological Evaluation
- Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer
- Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases
- p27 specifically decreases in squamous carcinoma, and mediates NNK-induced transformation of human bronchial epithelial cells
- Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
- Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case report
- Music therapy, quality of life and efficacy of immunotherapy for NSCLC
- The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort
- Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry
- Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry
- Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports
- Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis
- Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study
- SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS
- Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
- α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape
- Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer
- Genetic correlation and causal associations between psychiatric disorders and lung cancer risk